Clinical trial
A Randomized Controlled Trial Evaluating the Effect of the Oxytocin Infusion Rate on Fetal Heart Rate Changes and Maternal-Fetal Outcomes During the Initiation of Combined Spinal-Epidural Labor Analgesia
NCT03232918 is registered in ClinicalTrials.gov with Unyime Ituk as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial Evaluating the Effect of the Oxytocin Infusion Rate on Fetal Heart Rate Changes and Maternal-Fetal Outcomes During the Initiation of Combined Spinal-Epidural Labor Analgesia
- Lead sponsor
- Unyime Ituk
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- February 20, 2019
- Completion date
- December 31, 2025
- Enrollment
- 730 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
fetal bradycardia complicating labor and delivery, fetal bradycardia during labor, fetal heart rate or rhythm abnormality affecting fetus